-
First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people
expresspharma
October 22, 2020
Preliminary results from the late-stage human trial of Russia’s main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.
-
Chumakov Center initiates Covid-19 vaccine candidate trials
pharmaceutical-technology
October 22, 2020
Russia’s Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products has initiated clinical trials of its potential Covid-19 vaccine in St Petersburg.
-
Russia to supply Mexico with 32 million doses of Sputnik V
europeanpharmaceuticalreview
September 24, 2020
The Russian Direct Investment Fund (RDIF) said the supply of the COVID-19 vaccine should enable 25 percent of the population to be vaccinated.
-
An overview of Indian COVID-19 vaccine supply and development
europeanpharmaceuticalreview
September 22, 2020
Prashant Khadayate, Pharma Analyst at GlobalData, explains what the current state of the COVID-19 pandemic is in India and what vaccine options are currently under development/testing.
-
Russia’s Sputnik V COVID-19 vaccine safely elicits an antibody response, reports paper
europeanpharmaceuticalreview
September 08, 2020
Preliminary data from Phase I/II trails evaluating the vaccine reveal 100 percent of participants had a humoral and cellular response, with no serious adverse events reported.
-
Brazil’s Parana state to produce Russia’s Covid-19 vaccine
pharmaceutical-technology
August 14, 2020
The Russian Direct Investment Fund (RDIF) and the Brazilian state of Parana are set to collaborate to produce and distribute Russia’s registered Covid-19 vaccine, Sputnik V.
-
Russia approves world’s first Covid-19 vaccine
pharmaceutical-technology
August 13, 2020
Russia has awarded regulatory approval to a Covid-19 vaccine, becoming the first country in the world to register a coronavirus vaccine for use.